Trial Profile
A clinical proof of concept study of the hepatitis B vaccine VVX-001
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2018
Price :
$35
*
At a glance
- Drugs VVX 001 (Primary)
- Indications Hepatitis B
- Focus Proof of concept; Therapeutic Use
- 04 Sep 2018 New trial record